Open the app
Home › Markets › Finance › JRI

Nuveen Real Asset Income and Growth Fund Common Shares of Beneficial Interest (JRI)

JRI trades on NYSE in Finance, Finance Companies. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$10.55
-0.85% on the day
Market cap
Fund
Revenue
Fund: reports investment income, not revenue
Net income
Fund: reports investment income, not revenue

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerJRI on NYSE
SectorFinance
IndustryFinance Companies
CountryUnited States
IPO year2012
SEC CIK0001539337
Incorporated inMA

Financials

Fund: reports investment income, not revenue.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS FILED PURSUANT TO RULE 424(B)(5)
424B52026-01-27
Latest current report
NUVEEN REAL ASSET INCOME & GROWTH FUND
8-K2024-06-07
Latest proxy
NUVEEN REAL ASSET INCOME AND GROWTH FUND
DEF 14A2026-03-04

Source: SEC EDGAR submissions feed, 316 recent filings. All filings on EDGAR.

Peers in Finance Companies

TickerCompanyPriceDayMarket cap
NCZVirtus Convertible & Income Fund II Common Shares of Beneficial Interest$14.28-2.26%$1.1B
HQHabrdn Healthcare Investors Shares of Beneficial Interest$19.13-2.99%$905.7M
BSTBlackRock Science and Technology Trust Common Shares of Beneficial Interest$50.09-0.38%$1.1B
JCAPJefferson Capital Inc.$20.54+0.93%$1.2B
PRAAPRA Group Inc.$20.47+2.40%$770.7M
NCVVirtus Convertible & Income Fund Common Shares of Beneficial Interest$15.33-1.86%$1.4B
BDJBlackrock Enhanced Equity Dividend Trust$9.59-0.10%$1.7B
SWRDStewards Inc$2.50-4.21%$564.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier